Global PET Radiopharmaceuticals Market Professional Survey Report 2021

Published Date : 23-06-2021
Pages : 103
Report Id : 37109
Categories : Healthcare

This report studies the global PET Radiopharmaceuticals market status and forecast, categorizes the global PET Radiopharmaceuticals market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa).

The global PET Radiopharmaceuticals market is valued at xx million US$ in 2020 and is expected to reach xx million US$ by the end of 2027, growing at a CAGR of xx.x % between 2021 and 2027.

The major manufacturers covered in this report
Cardinal Health Inc. (U.S.)
Mallinckrodt plc (Ireland)
GE Healthcare (U.K.)
Lantheus Medical Imaging, Inc. (U.S.)
Bayer AG (Germany)
Bracco Imaging S.p.A (Italy)
Eczacibasi-Monrol Nuclear Products (Turkey)
Nordion, Inc. (Canada)
Advanced Accelerator Applications S.A. (France)
IBA Molecular Imaging (Belgium)

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
India
Southeast Asia
Other regions (Central & South America, Middle East & Africa)

The regional scope of the study is as follows:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
F-18
Ru-82
Others

By Application, the market can be split into
Oncology
Cardiology
Neurology
Others

The study objectives of this report are:
To analyze and study the global PET Radiopharmaceuticals capacity, production, value, consumption, status (2016-2020) and forecast (2021-2027);
Focuses on the key PET Radiopharmaceuticals manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of PET Radiopharmaceuticals are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
PET Radiopharmaceuticals Manufacturers
PET Radiopharmaceuticals Distributors/Traders/Wholesalers
PET Radiopharmaceuticals Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the PET Radiopharmaceuticals market, by end-use.
Detailed analysis and profiles of additional market players.

Table of Contents

Global PET Radiopharmaceuticals Market Professional Survey Report 2021
1 Industry Overview of PET Radiopharmaceuticals
1.1 Definition and Specifications of PET Radiopharmaceuticals
1.1.1 Definition of PET Radiopharmaceuticals
1.1.2 Specifications of PET Radiopharmaceuticals
1.2 Classification of PET Radiopharmaceuticals
1.2.1 F-18
1.2.2 Ru-82
1.2.3 Others
1.3 Applications of PET Radiopharmaceuticals
1.3.1 Oncology
1.3.2 Cardiology
1.3.3 Neurology
1.3.4 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India

2 Manufacturing Cost Structure Analysis of PET Radiopharmaceuticals
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of PET Radiopharmaceuticals
2.3 Manufacturing Process Analysis of PET Radiopharmaceuticals
2.4 Industry Chain Structure of PET Radiopharmaceuticals

3 Technical Data and Manufacturing Plants Analysis of PET Radiopharmaceuticals
3.1 Capacity and Commercial Production Date of Global PET Radiopharmaceuticals Major Manufacturers in 2020
3.2 Manufacturing Plants Distribution of Global PET Radiopharmaceuticals Major Manufacturers in 2020
3.3 R&D Status and Technology Source of Global PET Radiopharmaceuticals Major Manufacturers in 2020
3.4 Raw Materials Sources Analysis of Global PET Radiopharmaceuticals Major Manufacturers in 2020

4 Global PET Radiopharmaceuticals Overall Market Overview
4.1 2016-2021E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 2016-2021E Global PET Radiopharmaceuticals Capacity and Growth Rate Analysis
4.2.2 2020 PET Radiopharmaceuticals Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2016-2021E Global PET Radiopharmaceuticals Sales and Growth Rate Analysis
4.3.2 2020 PET Radiopharmaceuticals Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2016-2021E Global PET Radiopharmaceuticals Sales Price
4.4.2 2020 PET Radiopharmaceuticals Sales Price Analysis (Company Segment)

5 PET Radiopharmaceuticals Regional Market Analysis
5.1 North America PET Radiopharmaceuticals Market Analysis
5.1.1 North America PET Radiopharmaceuticals Market Overview
5.1.2 North America 2016-2021E PET Radiopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2016-2021E PET Radiopharmaceuticals Sales Price Analysis
5.1.4 North America 2020 PET Radiopharmaceuticals Market Share Analysis
5.2 Europe PET Radiopharmaceuticals Market Analysis
5.2.1 Europe PET Radiopharmaceuticals Market Overview
5.2.2 Europe 2016-2021E PET Radiopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2016-2021E PET Radiopharmaceuticals Sales Price Analysis
5.2.4 Europe 2020 PET Radiopharmaceuticals Market Share Analysis
5.3 China PET Radiopharmaceuticals Market Analysis
5.3.1 China PET Radiopharmaceuticals Market Overview
5.3.2 China 2016-2021E PET Radiopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China 2016-2021E PET Radiopharmaceuticals Sales Price Analysis
5.3.4 China 2020 PET Radiopharmaceuticals Market Share Analysis
5.4 Japan PET Radiopharmaceuticals Market Analysis
5.4.1 Japan PET Radiopharmaceuticals Market Overview
5.4.2 Japan 2016-2021E PET Radiopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan 2016-2021E PET Radiopharmaceuticals Sales Price Analysis
5.4.4 Japan 2020 PET Radiopharmaceuticals Market Share Analysis
5.5 Southeast Asia PET Radiopharmaceuticals Market Analysis
5.5.1 Southeast Asia PET Radiopharmaceuticals Market Overview
5.5.2 Southeast Asia 2016-2021E PET Radiopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2016-2021E PET Radiopharmaceuticals Sales Price Analysis
5.5.4 Southeast Asia 2020 PET Radiopharmaceuticals Market Share Analysis
5.6 India PET Radiopharmaceuticals Market Analysis
5.6.1 India PET Radiopharmaceuticals Market Overview
5.6.2 India 2016-2021E PET Radiopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2016-2021E PET Radiopharmaceuticals Sales Price Analysis
5.6.4 India 2020 PET Radiopharmaceuticals Market Share Analysis

6 Global 2016-2021E PET Radiopharmaceuticals Segment Market Analysis (by Type)
6.1 Global 2016-2021E PET Radiopharmaceuticals Sales by Type
6.2 Different Types of PET Radiopharmaceuticals Product Interview Price Analysis
6.3 Different Types of PET Radiopharmaceuticals Product Driving Factors Analysis
6.3.1 F-18 of PET Radiopharmaceuticals Growth Driving Factor Analysis
6.3.2 Ru-82 of PET Radiopharmaceuticals Growth Driving Factor Analysis
6.3.3 Others of PET Radiopharmaceuticals Growth Driving Factor Analysis

7 Global 2016-2021E PET Radiopharmaceuticals Segment Market Analysis (by Application)
7.1 Global 2016-2021E PET Radiopharmaceuticals Consumption by Application
7.2 Different Application of PET Radiopharmaceuticals Product Interview Price Analysis
7.3 Different Application of PET Radiopharmaceuticals Product Driving Factors Analysis
7.3.1 Oncology of PET Radiopharmaceuticals Growth Driving Factor Analysis
7.3.2 Cardiology of PET Radiopharmaceuticals Growth Driving Factor Analysis
7.3.3 Neurology of PET Radiopharmaceuticals Growth Driving Factor Analysis
7.3.4 Others of PET Radiopharmaceuticals Growth Driving Factor Analysis

8 Major Manufacturers Analysis of PET Radiopharmaceuticals
8.1 Cardinal Health Inc. (U.S.)
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Cardinal Health Inc. (U.S.) 2020 PET Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Cardinal Health Inc. (U.S.) 2020 PET Radiopharmaceuticals Business Region Distribution Analysis
8.2 Mallinckrodt plc (Ireland)
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Mallinckrodt plc (Ireland) 2020 PET Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Mallinckrodt plc (Ireland) 2020 PET Radiopharmaceuticals Business Region Distribution Analysis
8.3 GE Healthcare (U.K.)
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 GE Healthcare (U.K.) 2020 PET Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 GE Healthcare (U.K.) 2020 PET Radiopharmaceuticals Business Region Distribution Analysis
8.4 Lantheus Medical Imaging, Inc. (U.S.)
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 Lantheus Medical Imaging, Inc. (U.S.) 2020 PET Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Lantheus Medical Imaging, Inc. (U.S.) 2020 PET Radiopharmaceuticals Business Region Distribution Analysis
8.5 Bayer AG (Germany)
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Bayer AG (Germany) 2020 PET Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Bayer AG (Germany) 2020 PET Radiopharmaceuticals Business Region Distribution Analysis
8.6 Bracco Imaging S.p.A (Italy)
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Bracco Imaging S.p.A (Italy) 2020 PET Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Bracco Imaging S.p.A (Italy) 2020 PET Radiopharmaceuticals Business Region Distribution Analysis
8.7 Eczacibasi-Monrol Nuclear Products (Turkey)
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.2.1 Product A
8.7.2.2 Product B
8.7.3 Eczacibasi-Monrol Nuclear Products (Turkey) 2020 PET Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Eczacibasi-Monrol Nuclear Products (Turkey) 2020 PET Radiopharmaceuticals Business Region Distribution Analysis
8.8 Nordion, Inc. (Canada)
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.2.1 Product A
8.8.2.2 Product B
8.8.3 Nordion, Inc. (Canada) 2020 PET Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Nordion, Inc. (Canada) 2020 PET Radiopharmaceuticals Business Region Distribution Analysis
8.9 Advanced Accelerator Applications S.A. (France)
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.2.1 Product A
8.9.2.2 Product B
8.9.3 Advanced Accelerator Applications S.A. (France) 2020 PET Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Advanced Accelerator Applications S.A. (France) 2020 PET Radiopharmaceuticals Business Region Distribution Analysis
8.10 IBA Molecular Imaging (Belgium)
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.2.1 Product A
8.10.2.2 Product B
8.10.3 IBA Molecular Imaging (Belgium) 2020 PET Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 IBA Molecular Imaging (Belgium) 2020 PET Radiopharmaceuticals Business Region Distribution Analysis

9 Development Trend of Analysis of PET Radiopharmaceuticals Market
9.1 Global PET Radiopharmaceuticals Market Trend Analysis
9.1.1 Global 2021-2027 PET Radiopharmaceuticals Market Size (Volume and Value) Forecast
9.1.2 Global 2021-2027 PET Radiopharmaceuticals Sales Price Forecast
9.2 PET Radiopharmaceuticals Regional Market Trend
9.2.1 North America 2021-2027 PET Radiopharmaceuticals Consumption Forecast
9.2.2 Europe 2021-2027 PET Radiopharmaceuticals Consumption Forecast
9.2.3 China 2021-2027 PET Radiopharmaceuticals Consumption Forecast
9.2.4 Japan 2021-2027 PET Radiopharmaceuticals Consumption Forecast
9.2.5 Southeast Asia 2021-2027 PET Radiopharmaceuticals Consumption Forecast
9.2.6 India 2021-2027 PET Radiopharmaceuticals Consumption Forecast
9.3 PET Radiopharmaceuticals Market Trend (Product Type)
9.4 PET Radiopharmaceuticals Market Trend (Application)

10 PET Radiopharmaceuticals Marketing Type Analysis
10.1 PET Radiopharmaceuticals Regional Marketing Type Analysis
10.2 PET Radiopharmaceuticals International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of PET Radiopharmaceuticals by Region
10.4 PET Radiopharmaceuticals Supply Chain Analysis

11 Consumers Analysis of PET Radiopharmaceuticals
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 Conclusion of the Global PET Radiopharmaceuticals Market Professional Survey Report 2020
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of PET Radiopharmaceuticals
Table Product Specifications of PET Radiopharmaceuticals
Table Classification of PET Radiopharmaceuticals
Figure Global Production Market Share of PET Radiopharmaceuticals by Type in 2020
Figure F-18 Picture
Table Major Manufacturers of F-18
Figure Ru-82 Picture
Table Major Manufacturers of Ru-82
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of PET Radiopharmaceuticals
Figure Global Consumption Volume Market Share of PET Radiopharmaceuticals by Application in 2020
Figure Oncology Examples
Table Major Consumers in Oncology
Figure Cardiology Examples
Table Major Consumers in Cardiology
Figure Neurology Examples
Table Major Consumers in Neurology
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of PET Radiopharmaceuticals by Regions
Figure North America PET Radiopharmaceuticals Market Size (Million USD) ( 2016-2027)
Figure Europe PET Radiopharmaceuticals Market Size (Million USD) ( 2016-2027)
Figure China PET Radiopharmaceuticals Market Size (Million USD) ( 2016-2027)
Figure Japan PET Radiopharmaceuticals Market Size (Million USD) ( 2016-2027)
Figure Southeast Asia PET Radiopharmaceuticals Market Size (Million USD) ( 2016-2027)
Figure India PET Radiopharmaceuticals Market Size (Million USD) ( 2016-2027)
Table PET Radiopharmaceuticals Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of PET Radiopharmaceuticals in 2020
Figure Manufacturing Process Analysis of PET Radiopharmaceuticals
Figure Industry Chain Structure of PET Radiopharmaceuticals
Table Capacity and Commercial Production Date of Global PET Radiopharmaceuticals Major Manufacturers in 2020
Table Manufacturing Plants Distribution of Global PET Radiopharmaceuticals Major Manufacturers in 2020
Table R&D Status and Technology Source of Global PET Radiopharmaceuticals Major Manufacturers in 2020
Table Raw Materials Sources Analysis of Global PET Radiopharmaceuticals Major Manufacturers in 2020
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of PET Radiopharmaceuticals 2016-2021E
Figure Global 2016-2021E PET Radiopharmaceuticals Market Size (Volume) and Growth Rate
Figure Global 2016-2021E PET Radiopharmaceuticals Market Size (Value) and Growth Rate
Table 2016-2021E Global PET Radiopharmaceuticals Capacity and Growth Rate
Table 2020 Global PET Radiopharmaceuticals Capacity (K Pcs) List (Company Segment)
Table 2016-2021E Global PET Radiopharmaceuticals Sales (K Pcs) and Growth Rate
Table 2020 Global PET Radiopharmaceuticals Sales (K Pcs) List (Company Segment)
Table 2016-2021E Global PET Radiopharmaceuticals Sales Price (USD/Pcs)
Table 2020 Global PET Radiopharmaceuticals Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of PET Radiopharmaceuticals 2016-2021E
Figure North America 2016-2021E PET Radiopharmaceuticals Sales Price (USD/Pcs)
Figure North America 2020 PET Radiopharmaceuticals Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of PET Radiopharmaceuticals 2016-2021E
Figure Europe 2016-2021E PET Radiopharmaceuticals Sales Price (USD/Pcs)
Figure Europe 2020 PET Radiopharmaceuticals Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of PET Radiopharmaceuticals 2016-2021E
Figure China 2016-2021E PET Radiopharmaceuticals Sales Price (USD/Pcs)
Figure China 2020 PET Radiopharmaceuticals Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of PET Radiopharmaceuticals 2016-2021E
Figure Japan 2016-2021E PET Radiopharmaceuticals Sales Price (USD/Pcs)
Figure Japan 2020 PET Radiopharmaceuticals Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of PET Radiopharmaceuticals 2016-2021E
Figure Southeast Asia 2016-2021E PET Radiopharmaceuticals Sales Price (USD/Pcs)
Figure Southeast Asia 2020 PET Radiopharmaceuticals Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of PET Radiopharmaceuticals 2016-2021E
Figure India 2016-2021E PET Radiopharmaceuticals Sales Price (USD/Pcs)
Figure India 2020 PET Radiopharmaceuticals Sales Market Share
Table Global 2016-2021E PET Radiopharmaceuticals Sales (K Pcs) by Type
Table Different Types PET Radiopharmaceuticals Product Interview Price
Table Global 2016-2021E PET Radiopharmaceuticals Sales (K Pcs) by Application
Table Different Application PET Radiopharmaceuticals Product Interview Price
Table Cardinal Health Inc. (U.S.) Information List
Table Product A Overview
Table Product B Overview
Table 2020 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2020 Cardinal Health Inc. (U.S.) PET Radiopharmaceuticals Business Region Distribution
Table Mallinckrodt plc (Ireland) Information List
Table Product A Overview
Table Product B Overview
Table 2020 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2020 Mallinckrodt plc (Ireland) PET Radiopharmaceuticals Business Region Distribution
Table GE Healthcare (U.K.) Information List
Table Product A Overview
Table Product B Overview
Table 2015 GE Healthcare (U.K.) PET Radiopharmaceuticals Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2020 GE Healthcare (U.K.) PET Radiopharmaceuticals Business Region Distribution
Table Lantheus Medical Imaging, Inc. (U.S.) Information List
Table Product A Overview
Table Product B Overview
Table 2020 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2020 Lantheus Medical Imaging, Inc. (U.S.) PET Radiopharmaceuticals Business Region Distribution
Table Bayer AG (Germany) Information List
Table Product A Overview
Table Product B Overview
Table 2020 Bayer AG (Germany) PET Radiopharmaceuticals Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2020 Bayer AG (Germany) PET Radiopharmaceuticals Business Region Distribution
Table Bracco Imaging S.p.A (Italy) Information List
Table Product A Overview
Table Product B Overview
Table 2020 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2020 Bracco Imaging S.p.A (Italy) PET Radiopharmaceuticals Business Region Distribution
Table Eczacibasi-Monrol Nuclear Products (Turkey) Information List
Table Product A Overview
Table Product B Overview
Table 2020 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2020 Eczacibasi-Monrol Nuclear Products (Turkey) PET Radiopharmaceuticals Business Region Distribution
Table Nordion, Inc. (Canada) Information List
Table Product A Overview
Table Product B Overview
Table 2020 Nordion, Inc. (Canada) PET Radiopharmaceuticals Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2020 Nordion, Inc. (Canada) PET Radiopharmaceuticals Business Region Distribution
Table Advanced Accelerator Applications S.A. (France) Information List
Table Product A Overview
Table Product B Overview
Table 2020 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure 2020 Advanced Accelerator Applications S.A. (France) PET Radiopharmaceuticals Business Region Distribution
Table IBA Molecular Imaging (Belgium) Information List

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Direct Purchase

Your perfect start with Research Allied

Select a license type that your business needs

Single User License - 2800

Multi User License - 3800

Enterprise User License - 4800

Want to customize this report?

This report can be customized according to your requirements. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase.

Enquiry before buy